Last $5.10 USD
Change Today +0.06 / 1.19%
Volume 2.9M
NVAX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - NOVAVAX INC (NVAX)

Novavax, Inc. to Report Q3, 2014 on Nov 05, 2014
CapIQ 11/05/2014 9:30 PM ET
Novavax, Inc. to Report Q2, 2014 on Aug 06, 2014
CapIQ 11/05/2014 9:30 PM ET
Novavax, Inc. to Report Q1, 2014 on May 07, 2014
CapIQ 11/05/2014 9:30 PM ET

2013 revenues at Novavax, Inc. totaled $20.9M USD, while annual losses equaled $0.31 per share.

Quarterly Earnings & Estimates - NOVAVAX INC (NVAX)

Actuals vs. Estimates for NOVAVAX INC NVAX

Novavax, Inc.'s Quarterly Earnings

Novavax, Inc. reported 2nd quarter 2014 losses of $0.08 per share on 08/8/2014.

Annual Earnings & Estimates - NOVAVAX INC (NVAX)

Actuals vs. Estimates for NOVAVAX INC NVAX

Novavax, Inc.'s Annual Earnings

Novavax, Inc. reported annual 2013 losses of $0.31 per share on 03/12/2014.

Quarterly Revenues - NOVAVAX INC (NVAX)

Actuals vs. Estimates for NOVAVAX INC NVAX

Novavax, Inc.'s Quarterly Revenues

Novavax, Inc. had 2nd quarter 2014 revenues of $8.3M USD. This missed the $10.6M USD consensus estimate of the 3 analysts following the company. This was 133.9% above the prior year's 2nd quarter results.

Annual Revenues - NOVAVAX INC (NVAX)

Actuals vs. Estimates for NOVAVAX INC NVAX

Novavax, Inc.'s Annual Revenues

Novavax, Inc. had revenues for the full year 2013 of $20.9M USD. This was -5.3% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $5.10 USD +0.06

NVAX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Argos Therapeutics Inc $8.50 USD -0.41
Dynavax Technologies Corp $14.29 USD -0.22
Inovio Pharmaceuticals Inc $9.98 USD +0.03
Progenics Pharmaceuticals Inc $6.77 USD +0.35
ZIOPHARM Oncology Inc $3.86 USD +0.15
View Industry Companies
 

Industry Analysis

NVAX

Industry Average

Valuation NVAX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 37.2x
Price/Book 4.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 31.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.